Andrographis
Andrographis paniculata inhibits inflammation through andrographolide's suppression of NF-κB transcriptional activity, reducing pro-inflammatory cytokines TNF-α and IL-6 with IC₅₀ values of 2-2.4 μg/mL. The herb demonstrates immunomodulatory effects by blocking JAK/STAT signaling pathways and activating Nrf2/HO-1 antioxidant responses.

Origin & History
Andrographis paniculata, commonly known as the "King of Bitters," is a potent medicinal herb native to South Asia, widely cultivated in India, China, and Southeast Asia. Revered for its intensely bitter taste, it is a cornerstone of traditional medicine systems. This herb is valued for its significant immune-boosting, anti-inflammatory, and antiviral properties, making it a powerful agent for combating infections and supporting overall wellness.
Historical & Cultural Context
Known as the "King of Bitters," Andrographis has been a cornerstone of both Ayurvedic and Traditional Chinese Medicine for over 2,000 years. It was historically prized for its broad therapeutic properties, particularly in treating colds, fevers, digestive disorders, and respiratory infections, and for supporting liver health.
Health Benefits
- Modulates immune responses and exhibits antiviral activity through its primary bioactive, andrographolides. - Reduces systemic inflammation by inhibiting pro-inflammatory pathways. - Provides broad-spectrum antioxidant protection, safeguarding cells from oxidative damage. - Enhances immune function and supports collagen synthesis with its Vitamin C content. - Supports bone density and cellular signaling through essential calcium.
How It Works
Andrographolide and related compounds inhibit NF-κB transcriptional activity with IC₅₀ values of 2-2.4 μg/mL, reducing production of TNF-α, IL-6, MIP-2, and nitric oxide in stimulated macrophages. The herb blocks JAK/STAT signaling by inhibiting STAT1/2/3 phosphorylation and PI3K pathways while inducing apoptosis through caspase-3 activation and BAX upregulation. Additional mechanisms include Nrf2/HO-1 antioxidant pathway activation and ROS reduction via PKC modulation.
Scientific Research
Numerous clinical trials and meta-analyses support Andrographis' efficacy in reducing symptoms of upper respiratory tract infections, including the common cold. Studies highlight its anti-inflammatory and immunomodulatory effects, primarily attributed to andrographolides. Research also indicates potential benefits for liver health and detoxification.
Clinical Summary
Clinical evidence primarily consists of studies on upper respiratory tract infections, with meta-analyses supporting efficacy in reducing common cold symptoms and duration. Most documented research focuses on preclinical models demonstrating anti-inflammatory effects with statistical significance (P < 0.05) in cell and animal studies. Human clinical trial data with specific sample sizes and quantified outcomes remains limited in current literature. The strongest evidence supports immunomodulatory and anti-inflammatory properties, though more robust human studies are needed to establish definitive clinical parameters.
Nutritional Profile
- Vitamins: Vitamin C - Minerals: Calcium - Phytochemicals: Andrographolides, Flavonoids
Preparation & Dosage
- Tea: Brew 1-2 teaspoons of dried leaves or powder into a tea for immune support and detoxification. - Capsule: Consume standardized extracts, typically 400–600 mg daily, for concentrated benefits. - Tincture: Utilize liquid extracts for potentially faster absorption, especially during acute immune challenges.
Synergy & Pairings
Role: Herbal amplifier Intention: Immune & Inflammation | Detox & Liver Primary Pairings: Turmeric (Curcuma longa); Elderberry (Sambucus nigra); Milk Thistle (Silybum marianum)
Safety & Interactions
Current research lacks comprehensive safety data, drug interaction profiles, and specific contraindications for andrographis supplementation. The bitter taste may cause gastrointestinal discomfort in sensitive individuals, and the herb's immunomodulatory effects could theoretically interact with immunosuppressive medications. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential uterine stimulant properties. Patients on anticoagulant medications should exercise caution as andrographis may affect bleeding time, though specific interaction studies are not well-documented.